Table 1:
Demographic features and underlying conditions on or in the 90 days before index date among patients with blastomycosis, coccidioidomycosis, histoplasmosis, or other respiratory infections, 2016–2017
| Coccidioidomycosis | Histoplasmosis | Blastomycosis | S. pneumoniae pneumonia | Bacterial pneumonia | Pneumonia, organism unspecified | Viral pneumonia | Influenza | Bronchitis or unspecified lower acute respiratory infection | Acute nasopharyngitis or upper acute respiratory infections of multiple and unspecified sites | Respiratory tuberculosis | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| n=1,929 | n=2,205 | n=268 | n=3,272 | n=42,602 | n=302,675 | n=5,233 | n=307,648 | n=1,120,957 | n=1,934,543 | n=3,659 | |
| Demographic features | |||||||||||
| Median age, years | 50.9 | 55.8 | 56.4 | 60.7 | 58.3 | 56.3 | 58.7 | 42.8 | 48.3 | 43.8 | 49.3 |
| Age group, years | |||||||||||
| 18–34 | 14.9% | 11.9% | 12.3% | 8.4% | 13.2% | 14.0% | 12.4% | 32.5% | 21.4% | 31.5% | 23.1% |
| 35–44 | 16.8% | 12.2% | 8.6% | 10.4% | 10.9% | 12.8% | 11.3% | 21.4% | 18.0% | 19.6% | 16.6% |
| 45–54 | 24.7% | 18.1% | 20.2% | 15.2% | 15.6% | 17.6% | 16.1% | 21.9% | 23.1% | 21.1% | 21.0% |
| 55–64 | 30.0% | 29.0% | 28.0% | 27.9% | 24.9% | 25.9% | 24.6% | 18.8% | 26.0% | 20.4% | 23.0% |
| 65 and older | 13.6% | 28.8% | 31.0% | 38.1% | 35.3% | 29.7% | 35.6% | 5.4% | 11.6% | 7.4% | 16.4% |
| Male | 52.1% | 43.9% | 75.8% | 45.3% | 46.3% | 45.5% | 43.8% | 41.9% | 39.0% | 37.4% | 40.2% |
| Census region* | |||||||||||
| Northeast | 4.3% | 7.2% | 16.8% | 21.9% | 21.0% | 19.2% | 23.4% | 14.4% | 15.8% | 17.6% | 23.7% |
| Midwest | 6.0% | 43.0% | 39.2% | 29.7% | 25.1% | 25.9% | 24.4% | 13.8% | 20.9% | 17.0% | 16.1% |
| South | 8.8% | 42.6% | 37.3% | 37.6% | 42.7% | 41.1% | 39.0% | 63.0% | 52.6% | 52.8% | 38.4% |
| West | 80.6% | 7.0% | 6.7% | 10.9% | 11.0% | 13.7% | 12.9% | 8.5% | 10.5% | 12.3% | 21.7% |
| Unknown | 0.3% | 0.1% | 0.0% | 0.1% | 0.2% | 0.2% | 0.2% | 0.3% | 0.2% | 0.3% | 0.2% |
| Underlying conditions | |||||||||||
| COPD or other chronic lower respiratory disease | 10.2% | 12.2% | 10.1% | 23.3% | 21.1% | 16.2% | 20.2% | 3.5% | 6.8% | 3.3% | 11.0% |
| Asthma | 10.0% | 6.9% | 4.9% | 10.1% | 10.1% | 9.0% | 11.9% | 4.3% | 8.1% | 4.9% | 7.0% |
| Diabetes | 13.8% | 15.8% | 23.1% | 18.8% | 18.6% | 16.1% | 18.9% | 6.7% | 9.7% | 7.2% | 11.8% |
| Immunocompromised** | 12.2% | 14.0% | 11.6% | 9.6% | 7.8% | 6.3% | 11.6% | 2.8% | 3.4% | 2.9% | 20.5% |
*
primary beneficiary’s residence
**
HIV, hematologic malignancy, immune-mediated inflammatory disease, or solid organ or stem cell transplant